NL8102384A - L-carnitine en l-acylcarnitine-derivaten bevattende farmaceutische preparaten, alsmede therapeutische werkwijze voor de behandeling van diabetes mellitus bij jeugdigen. - Google Patents

L-carnitine en l-acylcarnitine-derivaten bevattende farmaceutische preparaten, alsmede therapeutische werkwijze voor de behandeling van diabetes mellitus bij jeugdigen. Download PDF

Info

Publication number
NL8102384A
NL8102384A NL8102384A NL8102384A NL8102384A NL 8102384 A NL8102384 A NL 8102384A NL 8102384 A NL8102384 A NL 8102384A NL 8102384 A NL8102384 A NL 8102384A NL 8102384 A NL8102384 A NL 8102384A
Authority
NL
Netherlands
Prior art keywords
carnitine
insulin
diabetes mellitus
pharmacologically acceptable
patients
Prior art date
Application number
NL8102384A
Other languages
English (en)
Dutch (nl)
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of NL8102384A publication Critical patent/NL8102384A/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Emergency Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NL8102384A 1980-05-15 1981-05-14 L-carnitine en l-acylcarnitine-derivaten bevattende farmaceutische preparaten, alsmede therapeutische werkwijze voor de behandeling van diabetes mellitus bij jeugdigen. NL8102384A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT4869280 1980-05-15
IT48692/80A IT1133010B (it) 1980-05-15 1980-05-15 Metodo terapuetico per il trattamento del diabete mellito a insorgenza giovanile e composizione farmaceutica per tale metodo

Publications (1)

Publication Number Publication Date
NL8102384A true NL8102384A (nl) 1981-12-01

Family

ID=11268073

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8102384A NL8102384A (nl) 1980-05-15 1981-05-14 L-carnitine en l-acylcarnitine-derivaten bevattende farmaceutische preparaten, alsmede therapeutische werkwijze voor de behandeling van diabetes mellitus bij jeugdigen.

Country Status (14)

Country Link
US (1) US4362719A (it)
JP (1) JPS579721A (it)
AU (1) AU540859B2 (it)
BE (1) BE888797A (it)
CA (1) CA1173749A (it)
CH (1) CH654208A5 (it)
DE (1) DE3119460A1 (it)
FR (1) FR2482588B1 (it)
GB (1) GB2075838B (it)
IE (1) IE51224B1 (it)
IL (1) IL62847A (it)
IT (1) IT1133010B (it)
NL (1) NL8102384A (it)
SE (1) SE8103003L (it)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1157238B (it) * 1982-10-29 1987-02-11 Sigma Tau Ind Farmaceuti Impiego di 1-carnitina per migliorare i paramenti biochimici e comportamentali dell'eta' senile
IT1237343B (it) * 1984-03-28 1993-05-31 Francia Farma Dicloridrato di acetildicarnitina, procedimento per la sua preparazione e composizioni farmaceutiche che lo contengono
US4537772A (en) * 1984-05-02 1985-08-27 Merck & Co., Inc. Enhancing absorption of drugs from gastrointestinal tract using acylcarnitines
US4897355A (en) 1985-01-07 1990-01-30 Syntex (U.S.A.) Inc. N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
US5545412A (en) * 1985-01-07 1996-08-13 Syntex (U.S.A.) Inc. N-[1, (1-1)-dialkyloxy]-and N-[1, (1-1)-dialkenyloxy]-alk-1-yl-n,n,n-tetrasubstituted ammonium lipids and uses therefor
US4731360A (en) * 1985-08-16 1988-03-15 Merck & Co., Inc. Acylcarnitines as absorption-enhancing agents for drug delivery through mucous membranes of the nasal, buccal, sublingual and vaginal compartments
DE3635864A1 (de) * 1986-06-26 1988-05-05 Gerhard Gergely Verfahren zum herstellen eines brausegranulates, danach hergestelltes brausegranulat sowie dessen verwendung
US5078997A (en) * 1988-07-13 1992-01-07 Cetus Corporation Pharmaceutical composition for interleukin-2 containing physiologically compatible stabilizers
IL99699A (en) * 1990-10-10 2002-04-21 Autoimmune Inc Drug with the option of oral, intra-intestinal, or inhaled dosing for suppression of autoimmune response associated with type I diabetes
US5321009A (en) * 1991-04-03 1994-06-14 American Home Products Corporation Method of treating diabetes
US5420108A (en) * 1992-09-14 1995-05-30 Shohet; Isaac H. Method of controlling diabetes mellitus
US6046232A (en) * 1997-10-17 2000-04-04 Centaur Pharmaceuticals, Inc. α-aryl-N-alkylnitrones and pharmaceutical compositions containing the same
IT1306178B1 (it) * 1999-07-27 2001-05-30 Sigma Tau Ind Farmaceuti Uso della l-carnitina e dei suoi alcanoil derivati per la preparazionedi un medicamento utile nel trattamento del paziente affetto da
US6835754B2 (en) 2001-01-08 2004-12-28 Renovis, Inc. Use of aryl nitrone compounds in methods for treating neuropathic pain
US20050232911A1 (en) * 2004-04-19 2005-10-20 Schreiber Brian D Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid
ITRM20040327A1 (it) * 2004-07-01 2004-10-01 Sigma Tau Ind Farmaceuti Uso della acetil l-carnitina per la preparazione di un medicamento per il trattamento del dolore neuropatico in pazienti diabetici.
RU2324479C2 (ru) * 2006-07-11 2008-05-20 Денис Владимирович Сидько Способ комплексной инфузионной терапии у больных с гипергликемической кетоацидотической диабетической комой
EP2162127A1 (en) * 2007-05-24 2010-03-17 SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. Composition useful for the prevention of adverse effect due to the use of ppar-gamma agonists
CN107121540B (zh) * 2016-02-24 2020-06-12 中国科学院上海营养与健康研究所 酰基肉碱谱或其检测试剂在2型糖尿病发病风险预测中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3624887A (en) * 1970-03-02 1971-12-07 Bunker Ramo Pin and socket removal tool
US3810994A (en) * 1972-06-01 1974-05-14 Ethyl Corp Method and composition for treating obesity
JPS5058213A (it) * 1973-09-26 1975-05-21
FR2414914A1 (fr) * 1978-01-18 1979-08-17 Sigma Tau Ind Farmaceuti Utilisations therapeutiques nouvelles de l'acetyl-1-carnitine et d'autres derives acyles de la 1-carnitine

Also Published As

Publication number Publication date
FR2482588A1 (fr) 1981-11-20
IL62847A0 (en) 1981-07-31
CH654208A5 (it) 1986-02-14
IE51224B1 (en) 1986-11-12
FR2482588B1 (fr) 1986-03-07
JPS579721A (en) 1982-01-19
AU7048681A (en) 1981-11-26
CA1173749A (en) 1984-09-04
DE3119460A1 (de) 1982-03-04
US4362719A (en) 1982-12-07
BE888797A (fr) 1981-08-28
GB2075838A (en) 1981-11-25
IT1133010B (it) 1986-07-09
IT8048692A0 (it) 1980-05-15
IL62847A (en) 1985-01-31
IE811011L (en) 1981-11-15
GB2075838B (en) 1984-05-10
AU540859B2 (en) 1984-12-06
SE8103003L (sv) 1981-11-16

Similar Documents

Publication Publication Date Title
NL8102384A (nl) L-carnitine en l-acylcarnitine-derivaten bevattende farmaceutische preparaten, alsmede therapeutische werkwijze voor de behandeling van diabetes mellitus bij jeugdigen.
HOFMANN et al. Glucose transport deficiency in diabetic animals is corrected by treatment with the oral antihyperglycemic agent pioglitazone
Lemann et al. Evidence that glucose ingestion inhibits net renal tubular reabsorption of calcium and magnesium in man
Martin et al. The fluid and electrolyte therapy of severe diabetic acidosis and ketosis: a study of twenty-nine episodes (twenty-six patients)
Gjedde Modulation of substrate transport to the brain
Khanna et al. Cytokine-induced glucose uptake in skeletal muscle: redox regulation and the role of α-lipoic acid
AU645076B2 (en) Use of 3-guanidinopropionic acid in the treatment and prevention of metabolic disorders
Nguyen et al. Increase in urinary calcium and oxalate after fructose infusion
Dellow et al. Elevated glycine betaine excretion in diabetes mellitus patients is associated with proximal tubular dysfunction and hyperglycemia
Borel et al. Hepatic glucose production and insulin sensitivity and responsiveness in iron-deficient anemic rats
Selye et al. On the therapeutic value of adrenal cortical hormones in traumatic shock and allied conditions
El Fouhil et al. An extract from date seeds stimulates endogenous insulin secretion in streptozotocin-induced type I diabetic rats
WO2003101469A1 (en) An oral composition with insulin-like activities and methods of use
BR0016131A (pt) Forma cristalina, formulação farmacêutica, uso de uma forma cristalina, uso de uma substância, métodos para tratamento ou a profilaxia de, condições associadas com reduzida sensibilidade à insulina, e de deslipidemia, diabetes melito do tipo 2, hiperglicemia, hiperinsulinemia, hipertensão arterial e/ou obesidade abdominal, e , processo para a preparação de uma forma cristalina de um composto de fórmula i
Charalampous et al. Acetylation in the diabetic rat
Bernard et al. An amino acid mixture improves glucose tolerance and lowers insulin resistance in the obese Zucker rat
US20060148758A1 (en) Method for blood glucose control in a mammal by N-acylated glucosamines
JPWO2005084660A1 (ja) ミトコンドリア病予防と対策
RU2035180C1 (ru) Антивирусное средство
Kordowiak et al. Insulin-like effects on liver Golgi membrane preparations of bis (oxalato) oxovanadate (IV) complex ion, a new vanadate compound
GITTLEMAN et al. Rickets associated with dwarfism, glycosuria, ketonuria and albuminuria
Patel et al. Valproate-induced Fanconi syndrome in a 27-year-old woman
Dayton et al. The Effect of Probenecid, Phenylbutazone, and Their Analogs on the Excretion of L-Ascorbic Acid in Rats1
Chan et al. Protein turnover in insulin-treated, alloxan-diabetic lean and obese Zucker rats
Derks et al. Disorders of carbohydrate absorption, transmembrane transport and metabolism

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
BV The patent application has lapsed